Immunohistochemistry as First-line Screening for Detecting Colorectal Cancer Patients at Risk for Hereditary Nonpolyposis Colorectal Cancer Syndrome A 2-antibody Panel May be as Predictive as a 4-antibody Panel

被引:140
作者
Shia, Jinru [1 ]
Tang, Laura H. [1 ]
Vakiani, Efsevia [1 ]
Guillem, Jose G. [2 ]
Stadler, Zsofia K. [3 ]
Soslow, Robert A. [1 ]
Katabi, Nora [1 ]
Weiser, Martin R. [2 ]
Paty, Philip B. [2 ]
Temple, Larissa K. [2 ]
Nash, Garrett M. [2 ]
Wong, W. Douglas [2 ]
Offit, Kenneth [3 ]
Klimstra, David S. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
关键词
DNA mismatch repair; HNPCC; Lynch syndrome; microsatellite instability; MSI; immunohistochemistry; DNA MISMATCH REPAIR; REVISED BETHESDA GUIDELINES; MICROSATELLITE INSTABILITY; LYNCH-SYNDROME; CHROMOSOME; TUMOR-CELLS; MSH2; EXPRESSION; PROTEINS; MUTATION;
D O I
10.1097/PAS.0b013e3181b15aa2
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The utility of immunohistochemical detection of DNA Mismatch repair proteins in screening colorectal cancer for hereditary nonpolyposis colorectal cancer (HNPCC) is being widely investigated. Currently, in both research and clinical settings. a 4-antibody panel that includes the 4 most commonly affected proteins (MLH1, MSH2, MSH6, and PMS2) is being used generally. On the basis of the biochemical properties of these proteins, we hypothesized that a 2-antibody panel, comprising MSH6 and PMS2, Would be sufficient to detect abnormalities in all 4 proteins. We tested this hypothesis on a series of 232 colorectal carcinoma samples derived from 2 patient cohorts: (1) a prospectively accrued series of patients who were judged to carry a higher-than-average risk for HNPCC based on the revised Bethesda guidelines (n = 190); and (2) a retrospective series of patients who were 40 years of age or younger (n = 42). Immunohistochemical stains were regarded as negative (protein lost), when there was no nuclear labeling in tumor cells (with positive internal control). Overall, 70 of the 232 tumors demonstrated loss of at least one protein. The most common abnormality was concurrent loss of MLH1 and PMS2 (observed in 17% of the cases), followed by concurrent loss of MSH2 and MSH6 (6%). All MLH1 and MSH2-abnormal cases were also abnormal for PMS2 and MSH6. respectively, whereas 9 of 50 PMS2 and 6 of 20 (30%) MSH6-abnormal cases showed only isolated loss of PMS2 or MSH6 (with normal staining for MLH1 and MSH2). As such, Our findings provide evidence that a 2-antibody panel (PMS2 and MSH6) is as effective as the current 4-antibody panel in detecting DNA mismatch repair protein abnormalities. Such a cost-effective approach carries significant implication, as immunohistochemistry is being widely used as first-line screening for HNPCC.
引用
收藏
页码:1639 / 1645
页数:7
相关论文
共 23 条
[1]   hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6 [J].
Acharya, S ;
Wilson, T ;
Gradia, S ;
Kane, MF ;
Guerrette, S ;
Marsischky, GT ;
Kolodner, R ;
Fishel, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13629-13634
[2]   The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch Syndrome: from bench to bedside [J].
Boland, C. Richard ;
Koi, Minoru ;
Chang, Dong K. ;
Carethers, John M. .
FAMILIAL CANCER, 2008, 7 (01) :41-52
[3]   Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing [J].
Christensen, M ;
Katballe, N ;
Wikman, F ;
Primdahl, H ;
Sorensen, FB ;
Laurberg, S ;
Orntoft, TF .
CANCER, 2002, 95 (11) :2422-2430
[4]   Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer [J].
de Jong, AE ;
van Puijenbroek, M ;
Hendriks, Y ;
Tops, C ;
Wijnen, J ;
Ausems, MGEM ;
Meijers-Heijboer, H ;
Wagner, A ;
van Os, TAM ;
Bröcker-Vriends, AHJT ;
Vasen, HFA ;
Morreau, H .
CLINICAL CANCER RESEARCH, 2004, 10 (03) :972-980
[6]   Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer [J].
Hampel, Heather ;
Frankel, Wendy L. ;
Martin, Edward ;
Arnold, Mark ;
Khanduja, Karamjit ;
Kuebler, Philip ;
Clendenning, Mark ;
Sotamaa, Kaisa ;
Prior, Thomas ;
Westman, Judith A. ;
Panescu, Jenny ;
Fix, Dan ;
Lockman, Janet ;
LaJeunesse, Jennifer ;
Comeras, Ilene ;
de la Chapelle, Albert .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) :5783-5788
[7]   Discrete in vivo roles for the MutL homologs Mlh2p and Mlh3p in the removal of frameshift intermediates in budding yeast [J].
Harfe, BD ;
Minesinger, BK ;
Jinks-Robertson, S .
CURRENT BIOLOGY, 2000, 10 (03) :145-148
[8]   Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancer [J].
Jenkins M.A. ;
Southey M.C. ;
Giles G.G. ;
Hopper J.L. .
Current Oncology Reports, 2007, 9 (3) :202-207
[9]  
KOI M, 1994, CANCER RES, V54, P4308
[10]  
Leach FS, 1996, CANCER RES, V56, P235